Shaobo Yao

1.8k total citations
60 papers, 1.2k citations indexed

About

Shaobo Yao is a scholar working on Oncology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shaobo Yao has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 16 papers in Surgery and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shaobo Yao's work include Peptidase Inhibition and Analysis (20 papers), Protease and Inhibitor Mechanisms (12 papers) and Neuroendocrine Tumor Research Advances (11 papers). Shaobo Yao is often cited by papers focused on Peptidase Inhibition and Analysis (20 papers), Protease and Inhibitor Mechanisms (12 papers) and Neuroendocrine Tumor Research Advances (11 papers). Shaobo Yao collaborates with scholars based in China, United States and Austria. Shaobo Yao's co-authors include Li Huo, Weibing Miao, Haiqun Xing, Wenjia Zhu, Marcus Hacker, Xiang Li, Zhaohui Zhu, Ximin Shi, Xiaobo Yang and Haitao Zhao and has published in prestigious journals such as PLoS ONE, Small and Journal of Medicinal Chemistry.

In The Last Decade

Shaobo Yao

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaobo Yao China 19 692 387 325 311 281 60 1.2k
Saila Kauhanen Finland 14 468 0.7× 344 0.9× 347 1.1× 265 0.9× 129 0.5× 26 1.0k
Paolo Esposto Pirani Italy 15 651 0.9× 101 0.3× 144 0.4× 206 0.7× 136 0.5× 31 1.3k
Matthias Lang Germany 8 1.1k 1.6× 527 1.4× 149 0.5× 330 1.1× 550 2.0× 16 1.3k
Joshua S. Silverman United States 16 354 0.5× 116 0.3× 337 1.0× 192 0.6× 75 0.3× 71 1.3k
Renê Gerhard Brazil 21 985 1.4× 385 1.0× 154 0.5× 65 0.2× 365 1.3× 41 1.8k
Jibing Chen China 25 924 1.3× 487 1.3× 114 0.4× 104 0.3× 170 0.6× 130 2.1k
Brian J. Yoder United States 18 670 1.0× 331 0.9× 75 0.2× 174 0.6× 290 1.0× 22 1.4k
Zhiyuan Xu United States 22 175 0.3× 247 0.6× 468 1.4× 85 0.3× 84 0.3× 52 1.4k
Yazmín Odia United States 20 205 0.3× 107 0.3× 143 0.4× 80 0.3× 195 0.7× 89 1.2k
Jacob Ruzevick United States 18 485 0.7× 126 0.3× 106 0.3× 51 0.2× 120 0.4× 49 1.1k

Countries citing papers authored by Shaobo Yao

Since Specialization
Citations

This map shows the geographic impact of Shaobo Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaobo Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaobo Yao more than expected).

Fields of papers citing papers by Shaobo Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaobo Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaobo Yao. The network helps show where Shaobo Yao may publish in the future.

Co-authorship network of co-authors of Shaobo Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Shaobo Yao. A scholar is included among the top collaborators of Shaobo Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaobo Yao. Shaobo Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Qing, et al.. (2025). Comparison of PET/CT using 68Ga-NOTA-Exendin-4 with 68Ga-DOTATATE, 18F-FDG, and conventional imaging in the localization of insulinomas. European Journal of Nuclear Medicine and Molecular Imaging. 52(11). 4102–4111.
2.
Chen, Yimin, Ming Wang, Xinlin Wang, et al.. (2025). Biphenyl-Trimeric PSMA Theranostic Platform Enables PET Imaging and Optical Detection of Prostate Cancer. Journal of Medicinal Chemistry. 68(12). 13075–13088.
3.
Wang, Ming, et al.. (2025). Recent Development of CXCR4-Targeted Nuclear Medicine Research in Adrenocortical Tumors. Mini-Reviews in Medicinal Chemistry. 25(16). 1227–1241. 1 indexed citations
4.
Li, Qing, et al.. (2025). Recent advances of FAPI PET tracers in the diagnosis of liver cancer. Clinical and Translational Imaging. 13(3). 241–260. 1 indexed citations
5.
Wang, Xinlin, Ming Wang, Yimin Chen, et al.. (2025). Preclinical evaluation and first-in-human study of 68Ga- and Al18F-Labeled PSMA/FAP bispecific tracers for prostate cancer imaging. European Journal of Nuclear Medicine and Molecular Imaging. 53(4). 2489–2501.
6.
Chen, Zhenying, Qianqian Xue, & Shaobo Yao. (2022). Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4for Imaging and Therapy in Related Disease. Mini-Reviews in Medicinal Chemistry. 23(7). 787–803. 10 indexed citations
7.
Wang, Chao, Rong Lin, & Shaobo Yao. (2022). Recent Advances in 18F-Labeled Amino Acids Synthesis and Application. Pharmaceutics. 14(10). 2207–2207. 7 indexed citations
8.
Chen, Shaoming, Zhenying Chen, Ke Zheng, et al.. (2022). Accurate preoperative staging with [68Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[18F]FDG PET/CT. European Radiology. 32(9). 6070–6079. 27 indexed citations
9.
Wang, Ying, Li Cai, Kaixiang Zhou, Mengchao Cui, & Shaobo Yao. (2022). Biodistribution and Dosimetry Evaluation for a Novel Tau Tracer [18F]-S16 in Healthy Volunteers and Its Application in Assessment of Tau Pathology in Alzheimer’s Disease. Frontiers in Bioengineering and Biotechnology. 9. 812818–812818. 6 indexed citations
10.
Zhu, Wenjia, Ru Jia, Qiao Yang, et al.. (2021). A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE. European Journal of Nuclear Medicine and Molecular Imaging. 49(5). 1613–1622. 25 indexed citations
11.
Zheng, Jieling, et al.. (2021). [68Ga]Ga-FAPI and [18F]FDG PET/CT images in a patient with juvenile polymyositis. European Journal of Nuclear Medicine and Molecular Imaging. 48(6). 2051–2052. 8 indexed citations
12.
Zhang, Ying, Jiawei Cai, Zanyi Wu, Shaobo Yao, & Weibing Miao. (2021). Intense [68Ga]Ga-FAPI-04 uptake in solitary fibrous tumor/hemangiopericytoma of the central nervous system. European Journal of Nuclear Medicine and Molecular Imaging. 48(12). 4103–4104. 7 indexed citations
13.
Shi, Ximin, Haiqun Xing, Xiaobo Yang, et al.. (2020). Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study. European Journal of Nuclear Medicine and Molecular Imaging. 48(5). 1593–1603. 111 indexed citations
14.
Ding, Jie, Yushi Zhang, Jin Wen, et al.. (2020). Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. European Journal of Nuclear Medicine and Molecular Imaging. 47(11). 2656–2665. 59 indexed citations
15.
Shi, Ximin, Haiqun Xing, Xiaobo Yang, et al.. (2020). Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 196–203. 96 indexed citations
16.
Zhu, Wenjia, Yuejuan Cheng, Xuezhu Wang, et al.. (2019). Head-to-Head Comparison of 68Ga-DOTA-JR11 and 68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: A Prospective Study. Journal of Nuclear Medicine. 61(6). 897–903. 59 indexed citations
17.
Luo, Yaping, Qingqing Pan, & Shaobo Yao. (2017). 68Ga-exendin-4 PET/CT for the localization of insulinomas. 37(3). 137–141.
18.
Wang, Hao, Bo Hou, Lin Lü, et al.. (2017). PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study. Journal of Nuclear Medicine. 59(3). 523–528. 47 indexed citations
19.
Zhang, Jingjing, Gang Niu, Lixin Lang, et al.. (2016). Clinical Translation of a Dual Integrin αvβ3– and Gastrin-Releasing Peptide Receptor–Targeting PET Radiotracer, 68Ga-BBN-RGD. Journal of Nuclear Medicine. 58(2). 228–234. 81 indexed citations
20.
Hu, Kongzhen, Xiaolan Tang, Ganghua Tang, et al.. (2015). 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging. PLoS ONE. 10(9). e0138675–e0138675. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saila Kauhanen Breakdown of academic impact, for papers by Paolo Esposto Pirani Breakdown of academic impact, for papers by Matthias Lang Breakdown of academic impact, for papers by Joshua S. Silverman Breakdown of academic impact, for papers by Renê Gerhard Breakdown of academic impact, for papers by Jibing Chen Breakdown of academic impact, for papers by Brian J. Yoder Breakdown of academic impact, for papers by Zhiyuan Xu Breakdown of academic impact, for papers by Yazmín Odia Breakdown of academic impact, for papers by Jacob Ruzevick
Rankless by CCL
2026